Royce & Associates’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,777,894
| Closed | -$1.01M | – | 811 |
|
2025
Q1 | $1.01M | Sell |
1,777,894
-187,220
| -10% | -$106K | 0.01% | 667 |
|
2024
Q4 | $4.15M | Buy |
1,965,114
+513,664
| +35% | +$1.08M | 0.04% | 522 |
|
2024
Q3 | $3.9M | Buy |
1,451,450
+10,000
| +0.7% | +$26.9K | 0.04% | 520 |
|
2024
Q2 | $4.11M | Buy |
1,441,450
+92,671
| +7% | +$264K | 0.04% | 513 |
|
2024
Q1 | $5.72M | Sell |
1,348,779
-102,050
| -7% | -$433K | 0.05% | 465 |
|
2023
Q4 | $7.76M | Buy |
1,450,829
+40,200
| +3% | +$215K | 0.07% | 386 |
|
2023
Q3 | $6.07M | Buy |
1,410,629
+9,800
| +0.7% | +$42.1K | 0.06% | 430 |
|
2023
Q2 | $7.69M | Sell |
1,400,829
-38,353
| -3% | -$211K | 0.07% | 386 |
|
2023
Q1 | $6.04M | Buy |
1,439,182
+14,319
| +1% | +$60.1K | 0.06% | 445 |
|
2022
Q4 | $3.95M | Sell |
1,424,863
-73,400
| -5% | -$203K | 0.04% | 527 |
|
2022
Q3 | $3.84M | Sell |
1,498,263
-122,000
| -8% | -$312K | 0.04% | 503 |
|
2022
Q2 | $5.83M | Sell |
1,620,263
-65,700
| -4% | -$237K | 0.06% | 431 |
|
2022
Q1 | $10.5M | Sell |
1,685,963
-127,200
| -7% | -$790K | 0.09% | 344 |
|
2021
Q4 | $12.8M | Sell |
1,813,163
-5,160
| -0.3% | -$36.4K | 0.1% | 337 |
|
2021
Q3 | $12.7M | Sell |
1,818,323
-195,627
| -10% | -$1.37M | 0.09% | 343 |
|
2021
Q2 | $16.8M | Buy |
2,013,950
+96,000
| +5% | +$800K | 0.12% | 306 |
|
2021
Q1 | $10.5M | Buy |
1,917,950
+252,350
| +15% | +$1.38M | 0.07% | 436 |
|
2020
Q4 | $7.15M | Buy |
1,665,600
+71,875
| +5% | +$308K | 0.06% | 469 |
|
2020
Q3 | $4.8M | Sell |
1,593,725
-280,875
| -15% | -$845K | 0.05% | 481 |
|
2020
Q2 | $5.81M | Buy |
1,874,600
+193,600
| +12% | +$600K | 0.06% | 420 |
|
2020
Q1 | $3.72M | Buy |
1,681,000
+30,000
| +2% | +$66.3K | 0.05% | 457 |
|
2019
Q4 | $5.04M | Sell |
1,651,000
-216,400
| -12% | -$660K | 0.05% | 491 |
|
2019
Q3 | $5.74M | Buy |
1,867,400
+37,600
| +2% | +$116K | 0.05% | 452 |
|
2019
Q2 | $3.66M | Buy |
1,829,800
+99,600
| +6% | +$199K | 0.03% | 567 |
|
2019
Q1 | $7.46M | Hold |
1,730,200
| – | – | 0.06% | 403 |
|
2018
Q4 | $5.5M | Buy |
1,730,200
+130,500
| +8% | +$415K | 0.05% | 477 |
|
2018
Q3 | $8.4M | Buy |
1,599,700
+34,700
| +2% | +$182K | 0.06% | 450 |
|
2018
Q2 | $8.37M | Buy |
1,565,000
+270,306
| +21% | +$1.45M | 0.06% | 446 |
|
2018
Q1 | $6.47M | Sell |
1,294,694
-202,406
| -14% | -$1.01M | 0.05% | 493 |
|
2017
Q4 | $4.94M | Sell |
1,497,100
-60,500
| -4% | -$200K | 0.03% | 589 |
|
2017
Q3 | $5.84M | Hold |
1,557,600
| – | – | 0.04% | 534 |
|
2017
Q2 | $3.97M | Hold |
1,557,600
| – | – | 0.03% | 660 |
|
2017
Q1 | $4.05M | Buy |
1,557,600
+44,000
| +3% | +$114K | 0.03% | 647 |
|
2016
Q4 | $4.62M | Sell |
1,513,600
-147,400
| -9% | -$450K | 0.03% | 600 |
|
2016
Q3 | $4.52M | Buy |
1,661,000
+115,000
| +7% | +$313K | 0.03% | 623 |
|
2016
Q2 | $4.42M | Hold |
1,546,000
| – | – | 0.03% | 624 |
|
2016
Q1 | $4.67M | Buy |
1,546,000
+225,000
| +17% | +$680K | 0.03% | 627 |
|
2015
Q4 | $4.58M | Sell |
1,321,000
-600
| -0% | -$2.08K | 0.03% | 639 |
|
2015
Q3 | $5M | Buy |
1,321,600
+1,400
| +0.1% | +$5.29K | 0.03% | 645 |
|
2015
Q2 | $7.53M | Buy |
1,320,200
+535,400
| +68% | +$3.05M | 0.03% | 634 |
|
2015
Q1 | $4.57M | Buy |
784,800
+10,000
| +1% | +$58.2K | 0.02% | 766 |
|
2014
Q4 | $4.39M | Hold |
774,800
| – | – | 0.02% | 809 |
|
2014
Q3 | $3.17M | Buy |
774,800
+7,700
| +1% | +$31.5K | 0.01% | 912 |
|
2014
Q2 | $3.49M | Hold |
767,100
| – | – | 0.01% | 939 |
|
2014
Q1 | $3.64M | Hold |
767,100
| – | – | 0.01% | 946 |
|
2013
Q4 | $3.61M | Sell |
767,100
-244,705
| -24% | -$1.15M | 0.01% | 959 |
|
2013
Q3 | $4.04M | Hold |
1,011,805
| – | – | 0.01% | 903 |
|
2013
Q2 | $3.63M | Buy |
+1,011,805
| New | +$3.63M | 0.01% | 930 |
|